Endothelial Stat3 activation promotes osteoarthritis development
Cell Proliferation · 2023-12 · 56 (12)
DOI: 10.1111/cpr.13518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 13.06.2023. Verfasst von Jiadong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Shanghai University, Shanghai, China. Hauptthemen laut MEDLINE: Cartilage, Articular, Osteoarthritis, STAT3 Transcription Factor. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The mechanism of the balance between subchondral angiogenesis and articular damage within osteoarthritis (OA) progression remains a mystery. However, the lack of specific drugs leads to limited clinical treatment options for OA, frequently failing to prevent eventual joint destruction in patients. Increasing evidence suggests that subchondral bone angiogenesis precedes cartilage injury, while proliferating endothelial cells (ECs) induce abnormal bone formation. Signal transducer and activator of transcription 3 (Stat3) is triggered by multiple cytokines in the OA microenvironment. Here, we observed elevated Stat3 activation in subchondral bone H‐type vessels. Endothelial Stat3 activation will lead to stronger cell proliferation, migration and angiogenesis by simulating ECs in OA. In contrast, either Stat3 activation inhibition or knockdown of Stat3 expression could relieve such alterations. More interestingly, blocking Stat3 in ECs alleviated angiogenesis‐mediated osteogenic differentiation and chondrocyte lesions. Stat3 inhibitor reversed surgically induced subchondral bone H‐type vessel hyperplasia in vivo, significantly downregulating vessel volume and vessel number. Due to the reduced angiogenesis, subchondral bone deterioration and cartilage loss were alleviated. Overall, our data suggest that endothelial Stat3 activation is an essential trigger for OA development. Therefore, targeted Stat3 blockade is a novel promising therapeutic regimen for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, Shanghai University, Shanghai, China.
- Organoid Research Center, Shanghai University, Shanghai, China.
- School of Medicine, Shanghai University, Shanghai, China.
- School of Life Sciences, Shanghai University, Shanghai, China.
- Department of Orthopedics, First Affiliated Hospital, Jinan University, Guangzhou, China.
- Department of Orthopedics, Shanghai Zhongye Hospital, Shanghai, China.
ORCID-Profile: Yingying Jiang, Jiacan Su
Förderung
- Key Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Zhang, W., Liu, X., Li, G., Gu, Y., Zhang, K., Shen, F., Wu, X., Jiang, Y., Zhang, Q., Zhou, F., Xu, K., & Su, J. (2023). Endothelial Stat3 activation promotes osteoarthritis development. Cell Proliferation, 56(12). https://doi.org/10.1111/cpr.13518
Vancouver
Li J, Zhang W, Liu X, Li G, Gu Y, Zhang K, et al. Endothelial Stat3 activation promotes osteoarthritis development. Cell Proliferation. 2023;56(12). doi:10.1111/cpr.13518
BibTeX
@article{Li2023,
author = {Li, Jiadong and Zhang, Wencai and Liu, Xinru and Li, Guangfeng and Gu, Yuyuan and Zhang, Kun and Shen, Fuming and Wu, Xiang and Jiang, Yingying and Zhang, Qin and Zhou, Fengjin and Xu, Ke and Su, Jiacan},
title = {Endothelial Stat3 activation promotes osteoarthritis development},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {12},
doi = {10.1111/cpr.13518}
}
EUVIMED